📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Amagma Therapeutics

1.1 - Company Overview

Amagma Therapeutics Logo

Amagma Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery and development of antibody therapeutics targeting inflammatory diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Amagma Therapeutics

Virdante Pharmaceuticals Logo

Virdante Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies, developing and commercializing drugs for autoimmune and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Virdante Pharmaceuticals company profile →
Apogee Therapeutics Logo

Apogee Therapeutics

HQ: United States Website
  • Description: Provider of antibody therapeutics for immunological and inflammatory disorders, including APG777 targeting IL-13 for atopic dermatitis, APG808 targeting IL-4Rα for chronic obstructive pulmonary disease, APG990 targeting OX40L for atopic dermatitis (preclinical), and APG222 dual-inhibiting OX40L and IL-13 for atopic dermatitis; designed for extended half-life and potentially less frequent dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apogee Therapeutics company profile →
SARcode Bioscience Logo

SARcode Bioscience

HQ: United States Website
  • Description: Provider of a novel class of small-molecule LFA-1 (CD11a/CD18; αLβ2) antagonists in development as topical agents to address significant unmet medical needs in ophthalmology, dermatology and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SARcode Bioscience company profile →
Gyre Therapeutics Logo

Gyre Therapeutics

HQ: United States Website
  • Description: Provider of protease therapeutics to address disorders of the coagulation system, operating as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gyre Therapeutics company profile →
Viela Bio Logo

Viela Bio

HQ: United States Website
  • Description: Provider of clinical-stage treatments for severe inflammation and autoimmune diseases, with a portfolio that selectively targets shared critical pathways at the root cause of disease; led by global leaders in inflammation and autoimmunity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viela Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Amagma Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Amagma Therapeutics

2.2 - Growth funds investing in similar companies to Amagma Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Amagma Therapeutics

4.2 - Public trading comparable groups for Amagma Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Amagma Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Amagma Therapeutics

What does Amagma Therapeutics do?

Amagma Therapeutics is a provider of discovery and development of antibody therapeutics targeting inflammatory diseases.

Who are Amagma Therapeutics's competitors?

Amagma Therapeutics's competitors and similar companies include Virdante Pharmaceuticals, Apogee Therapeutics, SARcode Bioscience, Gyre Therapeutics, and Viela Bio.

Where is Amagma Therapeutics headquartered?

Amagma Therapeutics is headquartered in United States.

How many employees does Amagma Therapeutics have?

Amagma Therapeutics has 1,000 employees 🔒.

When was Amagma Therapeutics founded?

Amagma Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Amagma Therapeutics in?

Amagma Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Amagma Therapeutics

Who are the top strategic acquirers in Amagma Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Amagma Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Amagma Therapeutics?

Top strategic M&A buyers groups and sectors for Amagma Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Amagma Therapeutics's sector and industry vertical

Which are the top PE firms investing in Amagma Therapeutics's sector and industry vertical?

Top PE firms investing in Amagma Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Amagma Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Amagma Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Amagma Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Amagma Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Amagma Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Amagma Therapeutics?

The key public trading comparables and valuation benchmarks for Amagma Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Amagma Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Amagma Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Amagma Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Amagma Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Amagma Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Amagma Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Amagma Therapeutics